Kathiresan Sekar
- SEC CIK
- 0001864112
No open-market purchases or sales filed in the past year.
Current role at each company
- MAZE Maze Therapeutics, Inc.Directoras of Sep 24, 2025
- VERV Verve Therapeutics, Inc.Chief Executive Officeras of Jul 28, 2025
- RLAY Relay Therapeutics, Inc.Directoras of Jun 6, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Kathiresan Sekar as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
VERV Verve Therapeutics, Inc.
Chief Executive Officer7 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 3, 2025 (view filing) | Apr 2 | 1 day | Kathiresan SekarChief Executive Officer | SSale | −9.82K | $4.15 | −$40.8K | −2.8%346.7K after | 10b5-1 |
| Oct 5, 2022 (view filing) | Oct 3 | 2 days | Kathiresan SekarChief Executive Officer | SSale | −50.0K | $33.65 | −$1.68M | −13.6%317.8K after | 3 lots |
| Aug 11, 2022 (view filing) | Aug 10 | 1 day | Kathiresan SekarChief Executive Officer | SSale | −50.0K | $29.90 | −$1.50M | −13.6%317.8K after | |
| Jul 21, 2022 (view filing) | Jul 19 | 2 days | Kathiresan SekarChief Executive Officer | SSale | −50.0K | $29.90 | −$1.50M | −13.6%317.8K after | |
| Jan 6, 2022 (view filing) | Jan 4 | 2 days | Kathiresan SekarChief Executive Officer | SSale | −1.87K | $39.90 | −$74.6K | −0.5%406.5K after | |
| Dec 29, 2021 (view filing) | Dec 27-28 | 2 days | Kathiresan SekarChief Executive Officer | SSale | −48.7K | $40.16 | −$1.96M | −10.7%406.5K after | 4 lots |
| Dec 27, 2021 (view filing) | Dec 22-23 | 5 days | Kathiresan SekarChief Executive Officer | SSale | −114.0K | $39.30 | −$4.48M | −21.9%406.5K after | 5 lots |